| Q37207085 | Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration |
| Q37104048 | Biomechanical signals suppress proinflammatory responses in cartilage: early events in experimental antigen-induced arthritis |
| Q36268243 | COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date |
| Q46911864 | Celecoxib inhibits nitric oxide production in chondrocytes of ligament-damaged osteoarthritic rat joints |
| Q35840709 | Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis |
| Q89066613 | Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis |
| Q47570656 | Current status and future prospects for disease modification in osteoarthritis. |
| Q41947962 | Cyclooxygenase inhibition lowers prostaglandin E2 release from articular cartilage and reduces apoptosis but not proteoglycan degradation following an impact load in vitro |
| Q28193949 | Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study |
| Q35875201 | Endoplasmic reticulum stress induces the expression of COX-2 through activation of eIF2α, p38-MAPK and NF-κB in advanced glycation end products stimulated human chondrocytes. |
| Q37773271 | Joint injury and osteoarthritis: soluble mediators in the course and treatment of cartilage pathology |
| Q38274496 | Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study |
| Q42701867 | Protective Roles of Selenium on Nitric Oxide and the Gene Expression of Inflammatory Cytokines Induced by Cadmium in Chicken Splenic Lymphocytes |
| Q42955515 | Radiation synovectomy with yttrium-90 for persisting arthritis has direct harmful effects on human cartilage that cannot be prevented by co-administration of glucocorticoids: an in vitro study |
| Q34286902 | Selective COX-2 inhibitor ameliorates osteoarthritis by repressing apoptosis of chondrocyte. |
| Q35592094 | Study of osteoarthritis treatment with anti-inflammatory drugs: cyclooxygenase-2 inhibitor and steroids |
| Q90415146 | The effect of non-steroidal anti-inflammatory drugs on matrix metalloproteinases levels in patients with osteoarthritis |
| Q33935081 | The effects of NSAIDs on types I, II, and III collagen metabolism in a rat osteoarthritis model |
| Q50940606 | The effects of rotenone-induced toxicity via the NF-κB-iNOS pathway in rat liver. |
| Q42137407 | The influence of scaffold material on chondrocytes under inflammatory conditions |